Who Has the Ability to Consent?
Click the red REGISTER button to pay the $10 fee and take the posttest.
Click here to return to the PCC CME article.
Does the capacity to consent vary between medical and psychiatric patients? Are tools needed to assess the patient’s decision-making capacity, or can the provider’s assessment be relied upon? Review the results of a study that sought answers to these questions in this CME journal activity.
Read the whole article at psychiatrist.com here:
Who Has the Ability to Consent?
© Copyright 2020 Physicians Postgraduate Press, Inc.
Primary care clinicians
Use assessment tools as needed to evaluate patients’ capacity to consent to treatment
Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.
After studying this article, you should be able to:
- Use assessment tools as needed to evaluate patients’ capacity to consent to treatment
Statement of Need and Purpose
Emergency department patient populations have a wide variety of illnesses, and their capacity to consent to treatment varies. Relying on the provider’s ability to determine the patient’s capacity to consent may not result in an accurate assessment. ED clinicians need education on when to use a tool and which one(s) can be administered efficiently to measure a patient’s ability to consent.
Release, Expiration, and Review Dates
This educational activity was published in August 2020 and is eligible for AMA PRA Category 1 Credit™ through August 31, 2022. The latest review of this material was August 2020.
Disclosure of off-label usage
The authors have determined that, to the best of their knowledge, no investigational information about pharmaceutical agents or device therapies that is outside US Food and Drug Administration–approved labeling has been presented in this activity.
La Vonne Ann Downey, PhD*
Department of Health Administration/Health Sciences, Roosevelt University, Chicago, Illinois
Les Zun, MD
Department of Emergency Medicine, Chicago Medical School, Chicago, Illinois
*Corresponding author: La Vonne Ann Downey, PhD, Department of Health Administration/Health Sciences, Roosevelt University, 430 S Michigan Ave, Chicago, IL 60605 (LDowney@roosevelt.edu).
All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Larry Culpepper, MD, MPH, Editor in Chief of The Primary Care Companion for CNS Disorders, has been a consultant for Acadia, Allergan, Eisai, Merck, Supernus, and Takeda; has been a stock shareholder of M-3 Information; and has received royalties from UpToDate and Oxford University Press. No member of the CME Institute staff reported any relevant personal financial relationships.
Drs Downey and Zun have no personal affiliations or financial relationships with any commercial interests to disclose relative to the article.
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation